Natural History of NAFLD

por Pais, Raluca, Maurel, Thomas
Publicado 2021

Neurocognitive impairment in obesity and liver disease—An unsolved mystery

por Kheloufi, Lyes, Weiss, Nicolas, Thabut, Dominique, Pais, Raluca
Publicado 2023

Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease

por Zambon Azevedo, Vittoria, Silaghi, Cristina Alina, Maurel, Thomas, Silaghi, Horatiu, Ratziu, Vlad, Pais, Raluca
Publicado 2022

Impact of steatosis and inflammation definitions on the performance of NASH tests

por Poynard, Thierry, Munteanu, Mona, Charlotte, Frederic, Perazzo, Hugo, Ngo, Yen, Deckmyn, Olivier, Pais, Raluca, Mathurin, Philippe, Ratziu, Vlad
Publicado 2018

Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease

por Nascimbeni, Fabio, Aron-Wisnewsky, Judith, Pais, Raluca, Tordjman, Joan, Poitou, Christine, Charlotte, Frederic, Bedossa, Pierre, Poynard, Thierry, Clément, Karine, Ratziu, Vlad
Publicado 2016

Clinical and genetic definition of serum bilirubin levels for the diagnosis of Gilbert syndrome and hypobilirubinemia

por Poynard, Thierry, Deckmyn, Olivier, Peta, Valentina, Sakka, Mehdi, Lebray, Pascal, Moussalli, Joseph, Pais, Raluca, Housset, Chantal, Ratziu, Vlad, Pasmant, Eric, Thabut, Dominique
Publicado 2023

Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population

por SILAGHI, CRISTINA ALINA, SILAGHI, HORATIU, COLOSI, HORATIU ALEXANDRU, CRACIUN, ANCA ELENA, FARCAS, ANCA, COSMA, DANIEL TUDOR, HANCU, NICOLAE, PAIS, RALUCA, GEORGESCU, CARMEN EMANUELA
Publicado 2016

The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis

por Poynard, Thierry, Peta, Valentina, Munteanu, Mona, Charlotte, Frederic, Ngo, Yen, Ngo, An, Perazzo, Hugo, Deckmyn, Olivier, Pais, Raluca, Mathurin, Philippe, Myers, Rob, Loomba, Rohit, Ratziu, Vlad
Publicado 2019

Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or...

por Deckmyn, Olivier, Poynard, Thierry, Bedossa, Pierre, Paradis, Valérie, Peta, Valentina, Pais, Raluca, Ratziu, Vlad, Thabut, Dominique, Brzustowski, Angelique, Gautier, Jean-François, Cacoub, Patrice, Valla, Dominique
Publicado 2022

Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes

por Poynard, Thierry, Peta, Valentina, Deckmyn, Olivier, Pais, Raluca, Ngo, Yen, Charlotte, Frederic, Ngo, An, Munteanu, Mona, Imbert-Bismut, Françoise, Monneret, Denis, Housset, Chantal, Thabut, Dominique, Valla, Dominique, Boitard, Christian, Castera, Laurent, Ratziu, Vlad
Publicado 2019

Long‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease

por Munteanu, Mona, Pais, Raluca, Peta, Valentina, Deckmyn, Olivier, Moussalli, Joseph, Ngo, Yen, Rudler, Marika, Lebray, Pascal, Charlotte, Frederic, Thibault, Vincent, Lucidarme, Olivier, Ngo, An, Imbert‐Bismut, Françoise, Housset, Chantal, Thabut, Dominique, Ratziu, Vlad, Poynard, Thierry
Publicado 2018

LCR1 and LCR2, two multi‐analyte blood tests to assess liver cancer risk in patients without or with cirrhosis

por Poynard, Thierry, Peta, Valentina, Deckmyn, Olivier, Munteanu, Mona, Moussalli, Joseph, Ngo, Yen, Rudler, Marika, Lebray, Pascal, Pais, Raluca, Bonyhay, Luminita, Charlotte, Frederic, Thibault, Vincent, Fartoux, Laetitia, Lucidarme, Olivier, Eyraud, Daniel, Scatton, Olivier, Savier, Eric, Valantin, Marc Antoine, Ngo, An, Drane, Fabienne, Rosmorduc, Olivier, Imbert‐Bismut, Françoise, Housset, Chantal, Thabut, Dominique, Ratziu, Vlad
Publicado 2018